Form 8-K

 

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): March 11, 2003

 

 

CRYO-CELL International, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

0-23386

 

22-3023093

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

3165 McMullen Booth Road, Bldg. B, Clearwater, FL

 

33761

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (727) 450-8000

 

 

Not applicable

(Former name or former address, if changed since last report)


 

Item 4.     Changes to Registrant’s Certifying Accountant.

 

On March 11, 2003, upon the recommendation and approval of its Board of Directors and its Audit Committee, CRYO-CELL International, Inc. (the “Company”) dismissed Weinick Sanders Leventhal & Co., LLP (“Weinick Sanders”) as the Company’s independent auditors. On the same date, the Company engaged Ernst & Young LLP (“E&Y”) to serve as the Company’s independent auditors.

 

Weinick Sanders’ reports on the Company’s consolidated financial statements for each of the fiscal years ended November 30, 2002 and 2001 did not contain an adverse opinion or disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles. During the fiscal years ended November 30, 2002 and 2001 and subsequently through the date of its dismissal, there were no disagreements with Weinick Sanders on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure which, if not resolved to Weinick Sanders’ satisfaction, would have caused them to make reference to the subject matter in connection with their report on the Company’s consolidated financial statements for such years. The Company requested Weinick Sanders Leventhal & Co., LLP to furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether Weinick Sanders Leventhal & Co., LLP agreed with certain statements. A copy of this letter is expected to be filed as an amendment to this Form 8-K when it is received.

 

During the fiscal years ended November 30, 2002 and 2001 and subsequently through the date of E&Y’s engagement, the Company did not consult E&Y with respect to the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s consolidated financial statements, or any disagreement or event described under Item 304(a)(i)(iv) of Regulation S-B.

 

Item 7.     Financial Statements and Exhibits

 

(c)   Exhibits.

 

99.1     Press Release dated March 14, 2003

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

CRYO-CELL INTERNATIONAL, INC.

   

(Registrant)

Date: March 14, 2003

 

By:

 

/s/     Jill M. Taymans


       

Name:     Jill M. Taymans

       

Title:       Vice President, Finance

 

 

3


 

EXHIBIT INDEX

 

 

Exhibit No.


  

Description


99.1

  

Press Release dated March 14, 2003

 

4